South San Francisco, CA — DC3 Therapeutics, LLC has secured $1,030,000.00 in new commercial financing for expansion opportunities in South San Francisco. According to the company website, DC3 Therapeutics is a full service Contract Research Organization (CRO). We offer a full set of services necessary for drug discovery, pre-clinical and IND enabling studies. Our services include histology and in vitro pharmacology as well as molecular, cellular, and micro-biology. We are happy to work with our clients to custom tailor experiments according to their research and development goals. Because we understand that drug development is a fast paced and demanding environment, we guarantee that our services are performed accurately. And to ensure a quick turn-around time, each customer is assigned a secured DC3 account to conveniently download data, schedule pickup, and submit inquiries.

To learn more about DC3 Therapeutics, LLC please visit: http://www.dc3therapeutics.com/

Company Contact:
Jonathan Wray, Managing Partner
415-594-9306
https://www.linkedin.com/in/jonathan-wray-999152142/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved